enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Morgan Stanley Doubles Vir Biotechnology Price Forecast ...

   www.aol.com/morgan-stanley-doubles-vir...

   On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid ...

3. What's Going On With Liver Disease Focused Vir Biotechnology ...

   www.aol.com/finance/whats-going-liver-disease...

   On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study evaluating combinations of tobevibart and elebsiran, with or without ...

4. Why Is Infectious Disease-Focused Vir Biotechnology Stock ...

   www.aol.com/finance/why-infectious-disease...

   On Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial evaluating tobevibart and elebsiran for chronic hepatitis ...

5. Vir Biotech slumps to over 3-year low as flu prevention ... - AOL

   www.aol.com/news/vir-biotech-slumps-over-3...

   News. Science & Tech. Shopping. Sports. Weather. 24/7 Help. For premium support please call: ... Vir Biotech slumps to over 3-year low as flu prevention therapy fails trial. July 20, 2023 at 12:37 PM

6. Time To Worry? Analysts Just Downgraded Their Vir ... - AOL

   www.aol.com/news/time-worry-analysts-just...

   The analysts covering Vir Biotechnology, Inc. ( NASDAQ:VIR ) delivered a dose of negativity to shareholders today, by...

7. Vir Biotechnology, Inc. (VIR) Soars 15.1%: Is Further Upside ...

   www.aol.com/news/vir-biotechnology-inc-vir-soars...

   Vir Biotechnology, Inc. (VIR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the ...

8. Vir Biotechnology, Inc. (VIR) Surges 32.1%: Is This an ...

   www.aol.com/news/vir-biotechnology-inc-vir...

   Vir Biotechnology, Inc. (VIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could ...

9. Vir Biotechnology, Inc. (VIR) Q1 Earnings and Revenues Beat ...

   www.aol.com/news/vir-biotechnology-inc-vir-q1...

   Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 19.94% and 80.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?